Omega Cash And Equivalents vs Net Tangible Assets Analysis
OHI Stock | USD 40.06 0.91 2.22% |
Omega Healthcare financial indicator trend analysis is much more than just breaking down Omega Healthcare Inv prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omega Healthcare Inv is a good investment. Please check the relationship between Omega Healthcare Cash And Equivalents and its Net Tangible Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Cash And Equivalents vs Net Tangible Assets
Cash And Equivalents vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omega Healthcare Inv Cash And Equivalents account and Net Tangible Assets. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Omega Healthcare's Cash And Equivalents and Net Tangible Assets is 0.18. Overlapping area represents the amount of variation of Cash And Equivalents that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Omega Healthcare Investors, assuming nothing else is changed. The correlation between historical values of Omega Healthcare's Cash And Equivalents and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Equivalents of Omega Healthcare Investors are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Cash And Equivalents i.e., Omega Healthcare's Cash And Equivalents and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.18 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Cash And Equivalents
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Omega Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omega Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Omega Healthcare's Selling General Administrative is increasing as compared to previous years. The Omega Healthcare's current Tax Provision is estimated to increase to about 3.4 M, while Issuance Of Capital Stock is projected to decrease to under 228.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.0B | 861.3M | 934.7M | 981.5M | Total Revenue | 1.1B | 878.2M | 949.7M | 997.2M |
Omega Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Omega Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omega Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.8B | 9.5B | 9.6B | 9.4B | 9.1B | 9.6B | |
Short Long Term Debt Total | 5.1B | 5.2B | 5.3B | 5.3B | 5.1B | 5.3B | |
Other Current Liab | 312.0M | 225.0M | 268.4M | 315.0M | 112.0M | 60.1M | |
Total Current Liabilities | 437.0M | 382.0M | 268.5M | 334.3M | 663.1M | 696.3M | |
Total Stockholder Equity | 4.1B | 3.8B | 3.9B | 3.6B | 3.6B | 3.8B | |
Property Plant And Equipment Net | (11.4M) | (10.8M) | (8.2M) | 17.8M | 30.2M | 28.7M | |
Net Debt | 5.1B | 5.0B | 5.2B | 5.0B | 4.6B | 4.9B | |
Retained Earnings | (1.8B) | (2.3B) | (2.5B) | (2.7B) | (3.2B) | (3.0B) | |
Non Current Assets Total | 8.6B | 8.1B | 8.2B | 7.6B | 8.3B | 8.8B | |
Non Currrent Assets Other | 7.3B | 6.8B | 6.9B | 6.8B | 7.5B | 7.9B | |
Other Assets | 830.5M | 7.8B | 7.4B | 6.9B | 6.0B | 6.3B | |
Net Receivables | 1.2B | 1.1B | 1.1B | 1.5B | 232.1M | 220.5M | |
Common Stock Shares Outstanding | 222.1M | 235.1M | 244.3M | 244.3M | 250.5M | 263.0M | |
Liabilities And Stockholders Equity | 9.8B | 9.5B | 9.6B | 9.4B | 9.1B | 9.6B | |
Non Current Liabilities Total | 5.0B | 5.1B | 5.3B | 5.3B | 5.0B | 5.3B | |
Other Stockholder Equity | 6.0B | 6.2B | 9.0B | 9.1B | 6.7B | 7.0B | |
Total Liab | 5.5B | 5.5B | 5.5B | 5.6B | 5.4B | 5.6B | |
Total Current Assets | 1.2B | 1.4B | 1.4B | 1.8B | 782.6M | 664.3M | |
Short Term Debt | 125M | 101.2M | 96K | 19.2M | 551.1M | 578.7M | |
Intangible Assets | 28.0M | 1.9M | 1.6M | 1.4M | 682K | 647.9K | |
Common Stock | 22.7M | 23.1M | 23.9M | 23.4M | 24.5M | 12.3M | |
Accumulated Other Comprehensive Income | (39.9M) | (12.8M) | (2.2M) | 20.3M | 29.3M | 30.8M | |
Other Liab | 71.5M | 10.8M | 8.2M | 21.8M | 25.1M | 23.9M | |
Cash | 24.1M | 163.5M | 20.5M | 297.1M | 442.8M | 465.0M | |
Long Term Debt | 389.7M | 369.5M | 5.3B | 5.3B | 5.0B | 5.3B | |
Cash And Short Term Investments | 24.1M | 163.5M | 20.5M | 297.1M | 442.8M | 465.0M | |
Property Plant Equipment | 7.2B | 6.7B | 6.8B | 6.5B | 7.5B | 7.9B | |
Common Stock Total Equity | 22.7M | 23.1M | 23.9M | 23.4M | 26.9M | 14.5M | |
Other Current Assets | (441.6M) | 85.5M | (287.5M) | (486.7M) | 107.7M | 113.0M | |
Net Tangible Assets | 3.5B | 3.2B | 3.3B | 3.0B | 3.4B | 2.6B | |
Noncontrolling Interest In Consolidated Entity | 201.2M | 194.7M | 201.4M | 193.9M | 223.0M | 182.8M | |
Accounts Payable | 5.1B | 280.8M | 268.5M | 315.0M | 362.3M | 664.3M | |
Good Will | 644.4M | 651.7M | 651.4M | 643.2M | 643.9M | 456.7M | |
Retained Earnings Total Equity | (1.8B) | (2.3B) | (2.5B) | (2.7B) | (2.5B) | (2.4B) | |
Long Term Debt Total | 389.7M | 369.5M | 5.3B | 5.3B | 6.1B | 6.4B | |
Capital Surpluse | 6.0B | 6.2B | 6.4B | 6.3B | 7.3B | 4.5B |
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.137 | Dividend Share 2.68 | Earnings Share 1.36 | Revenue Per Share 4.03 | Quarterly Revenue Growth 0.14 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.